Section 510(k) of the FD&C Act (amended on May 28, 1976, to include medical devices) requires device manufacturers who must register to submit a premarket notification (PMN) to the FDA, informing them of their intent to market a medical device at least 90 days in advance. A PMN helps the FDA determine whether a device is equivalent to one already placed into one of the three classification categories or if it’s a new device.
510(k) refers to section 510(k) of the Federal Food, Drug and Cosmetic Act.
* Source: https://www.fda.gov/training-and-continuing-education/cdrh-learn/510k-program-transcript
The Federal Food, Drug and Cosmetic Act does not specify who must submit a 510(k), but rather, which actions require a 510(k) submission.
* Source: https://www.fda.gov/medical-devices/premarket-submissions/premarket-notification-510k
A device is considered substantially equivalent if, in comparison to a predicate, it has the same intended use and technological characteristics as the predicate or if it has the same intended use as the predicate and has different technological characteristics and does not raise different questions of safety and effectiveness and the information submitted to FDA demonstrates that the device is as safe and effective as the legally marketed device.
* Source: https://www.fda.gov/medical-devices/premarket-submissions/premarket-notification-510k
A 510(k) is required when:
* Source: https://www.fda.gov/medical-devices/premarket-submissions/premarket-notification-510k
Learn how Arena’s product-centric quality management system (QMS) connects quality and product development processes helps medical device manufacturers overcome challenges to successfully deliver innovative, safe, and compliant products.